IL-33 activates the Th2-type immune response and pro-inflammatory cytokines, which are elevated in serum and tissue in atopic dermatitis 24,25, chronic asthma 5,26, and allergic rhinitis 27–29. This evidence concerns the gene IL33 and atopic eczema.